Weight-Loss Wonder Drugs, Online & Off The Rails, Pg14

Key Highlights:

• Experimental weight-loss drugs, retatrutide and zenagantide, are being sold online before receiving regulatory approval for routine use.
• These unapproved drugs are attracting attention due to promising clinical trial results, with retatrutide showing an average weight loss of 25% over 80 weeks.
• Concerns are rising over the safety, purity, dosage, and sterility of these online products, which are often counterfeit or incorrectly labeled.
• Social media influencers are actively promoting these investigational compounds and providing links to suppliers, bypassing medical supervision.
• Doctors warn against severe health risks, including gastrointestinal issues, cardiac problems, liver and pancreas damage, and sepsis, from using unregulated substances.
• Economic barriers, such as the lack of insurance coverage for approved anti-obesity medications in India, are pushing patients towards these illicit online alternatives.

Weight Loss Drug.jpg

Detailed Insights:

• The online trade of unapproved drugs thrives on high demand, social media hype, and the inability of many to access legitimate medical care for obesity.
• Retatrutide targets three receptors (GLP-1, GIP, and glucagon), while zenagantide (formerly amycretin) targets GLP-1 and amylin, aiming for greater weight loss through multiple biological pathways.
• In contrast, approved drugs like semaglutide (e.g., Wegovy) and tirzepatide (e.g., Zepbound) primarily mimic GLP-1 or a combination of GLP-1 and GIP, respectively, and have undergone rigorous US FDA approval processes.
• Online sellers often use disclaimers like "for research use only" to exploit legal loopholes, despite providing tools and instructions for personal use.
• Investigations have revealed overseas supply chains, including from China, making it difficult to trace the origin and quality of these products.
• The lack of outpatient insurance coverage for anti-obesity medications in India makes approved treatments prohibitively expensive, costing tens of thousands of rupees monthly.
• Regulators, cybercrime units, and social media platforms are urged to coordinate efforts to identify and shut down illicit vendors and combat medical misinformation.

Scientific/Technical Concepts Involved:

• GLP-1 (Glucagon-like peptide-1): A gut hormone that curbs appetite, slows gastric emptying, and helps regulate blood sugar.
• GIP (Glucose-dependent insulinotropic polypeptide): A gut hormone that enhances insulin secretion and influences fat metabolism.
• Glucagon: A hormone that raises blood sugar levels and may play a role in energy expenditure and fat burning.
• Amylin: A hormone co-secreted with insulin, involved in satiety and gastric emptying.
• BMI (Body Mass Index): A measure used to assess whether a person's weight is healthy in relation to their height.